ANDREA FRIESEN: Open Payments
NPI 1750374799 · LYNNWOOD, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$930 in 41 payments from 18 companies in 2025. Trend: 2023 $815 · 2024 $1,158 · 2025 $930
Food & beverage: $930
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 8 | $145 |
| Merck Sharp & Dohme LLC | 3 | $91 |
| AstraZeneca Pharmaceuticals LP | 4 | $85 |
| ABBVIE INC. | 3 | $69 |
| Amgen Inc. | 2 | $62 |
| Novo Nordisk Inc | 3 | $61 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| GlaxoSmithKline, LLC. | 3 | $60 |
| Kowa Pharmaceuticals America, Inc. | 2 | $57 |
| Teva Pharmaceuticals USA, Inc. | 2 | $47 |
Products named: REXULTI, M-M-R II, FARXIGA, ZORYVE, PREVNAR 20, ELIQUIS, AJOVY, Wegovy.
Industry payments across WA — which companies pay providers there.
